MetaCap

Co-Diagnostics (CODX) vs enVVeno Medical (NVNO)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.

Summary

Co-Diagnostics is the larger company by market cap ($7.6 million vs $5.7 million), about 1.3 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CODX-2.68%NVNO-2.68%
+0%-1%-3%
Oct 7, 20261 yearOct 8, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CODX versus NVNO key metrics
MetricCODXNVNO
Share price$1.09$8.18
Market cap$7.61M$5.68M
1-day change-2.68%-2.68%
EPS (TTM)$-26.14$-24.99
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$46.50$30.80
52-week low$0.906$7.01
Distance from 52-week high-97.66%-73.46%
Analyst consensusnonenone
Avg. price target upside+266.97%+266.97%
Average volume326.53K23.71K
Shares outstanding6.98M694.83K
Employees11533
SectorHealthcareHealthcare
IndustryMedical DevicesMedical Devices

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Co-Diagnostics

CODX stock →

Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally.

Healthcare · Medical Devices · 115 employees

About enVVeno Medical

NVNO stock →

enVVeno Medical Corporation, a medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease in the United States. The company's lead product is the VenoValve, a surgical replacement venous valve for the treatment of venous chronic venous insufficiency.

Healthcare · Medical Devices · 33 employees

CODX vs NVNO FAQ

Which is bigger, Co-Diagnostics or enVVeno Medical?

Co-Diagnostics (CODX) is larger, with a market capitalization of $7.61M compared with $5.68M for enVVeno Medical (NVNO).

Are Co-Diagnostics and enVVeno Medical in the same industry?

Yes. Both are classified in the Medical Devices industry within the Healthcare sector.

More comparisons